Semax vs Selank: What the Studies Measured
Semax and Selank are both seven-amino-acid peptides. The studies below ask different questions: how BDNF responds to Semax in rat brain tissue, and how anxiety symptoms changed in a clinical study involving Selank.
This comparison is structured to highlight practical differences in research context, mechanisms, and use-case fit.
By Maylene · Page updated
Semax
An ACTH analogue studied in rats for changes in brain-derived neurotrophic factor (BDNF), a protein involved in nerve-cell signalling.
Selank
A tuftsin analogue studied in people with anxiety disorders. The cited clinical study assessed symptoms and tolerability.
Side-by-Side Comparison
Use this table as a quick screening tool before reading the detailed sections below.
| Feature | Semax | Selank |
|---|---|---|
| Parent sequence | ACTH-derived | Tuftsin-derived |
| Study model | Rat hippocampus and basal forebrain in separate experiments | 60 patients in a comparative anxiety study |
| Measurement | BDNF protein and gene expression | Anxiety symptoms and treatment tolerability |
What does 1.4-fold mean?
In the hippocampus experiment, the largest measured BDNF protein level after Semax was 1.4 times the control level. A separate measurement found a threefold change in exon III BDNF messenger RNA. Messenger RNA carries instructions for protein synthesis, so these values describe different measurements.
Which brain region was studied?
Dolotov and colleagues published two papers in 2006. One studied the hippocampus. The other found a rise in BDNF in the rat basal forebrain after three hours. Neither experiment tested memory benefits in people.
What can be compared?
The Selank study measured clinical symptoms. It did not measure BDNF in the same model as the Semax experiments, so the results cannot rank the two peptides by their effects on BDNF.
The Verdict
The evidence on this page covers a molecular response in rats and symptom measurements in a separate human study. A direct comparison would require a common study population and endpoint.
Frequently Asked Questions
Did the BDNF protein level increase eightfold?
The cited hippocampus study reported a maximum 1.4-fold increase in BDNF protein. It reported a different change for BDNF messenger RNA.
Did either study compare Semax with Selank?
No. The Semax experiments used rat tissue. The Selank paper studied anxiety symptoms and tolerability in patients.
What do these studies establish about taking the peptides together?
The cited studies did not test the combination or its long-term safety.
Sources & evidence
These papers describe the stated compounds and study models. They do not test or certify Maylene products. Animal or cell findings do not establish human benefit, and pharmaceutical trials do not validate research-only pens.
- Semax and BDNF signalling — Dolotov et al., 2006
Rat hippocampal and behavioural experiments; not proof of cognitive improvement in people.
- Semax and BDNF in rat basal forebrain — Dolotov et al., 2006
A separate experiment measured BDNF protein in the basal forebrain and cerebellum.
- Selank and phenazepam comparison — Medvedev et al., 2014
Comparative clinical study of 60 patients. The abstract does not establish long-term safety or equivalence to all anxiety treatments.
Research Disclaimer
This comparison is for educational and informational purposes only. All information is based on published scientific research. Peptides sold by Maylene are intended solely for laboratory research use and are not for human consumption. Consult healthcare professionals before making any health decisions.
Research These Peptides
Neither compound in this comparison is in the current catalogue.
View All PeptidesMore Comparisons
Keep exploring related matchups to validate your shortlist across multiple dimensions.
Start Your Research Today
Compare current listings, labelled content and product documentation before ordering.
All compounds are supplied for laboratory and scientific research use only.
Shop Peptides